ClinicalTrials.gg
RecruitingNCT07183241H-REACTUpdated Oct 23, 2026

Hospital-to-Home Rehabilitation Through Exercise and Cognitive Training

An interventional study of Physical exercise and cognitive exercises in Acute Hospitalization, sponsored by Universidad Pública de Navarra. Recruiting at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Universidad Pública de Navarra · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 23, 2026Now RecruitingFirst site in Spain+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 597 studies in Motor Activity with a site in Spain — 148 open to participants now, 184 under way, 1 of them phase 3. Motor Activity · Spain.

Planned enrollment
100th of 539
200 · median 80
Started
2026
with 65 others
No phase
515 of 597
125 open now
Primary completion
2026-12
later than 113 of 183 live
Registered
487th of 597
by date

Among the 597 studies in Motor Activity with a site in Spain, this one is the 100th largest by planned enrollment of the 539 interventional ones that give a count, is one of 66 that started in 2026, is one of 515 with no phase, reaches primary completion later than 113 of the 183 other live ones, and was the 487th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

148 of the 597 studies in Motor Activity with a site in Spain are open now. Recruiting first, the newest first:

142 more — sign in →

All 148 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 597 studies in Motor Activity with a site in Spain, or all of them as a file.
02

Study summary

This research project is structured in two phases: an initial observational phase and a subsequent randomized controlled trial (RCT) phase. The goal of the observational phase is to compare hospital admission and Hospital at Home (HaH). The objective of the RCT is to assess the effectiveness of a multicomponent intervention following acute hospitalization in older adults. The main questions it aims to answer are:

  • What are the differences between hospital admission and HaH in sedentary and physical activity levels?
  • What are the effects of a multicomponent intervention following acute hospitalization in older adults?

Researchers will compare a post-discharge multicomponent intervention to usual care to see the effects on physical and cognitive function.

Participants will receive a home-based cognitive and physical exercise intervention or usual care.

03

Conditions studied

  • Acute Hospitalization

Browse trials for

Keywords

  • acute hospitalization
  • older adults
  • exercise
  • hospital at home
  • cognitive
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults admitted to the hospital or Hospital at Home (HaH) due to an acute illness.
  • Residents of Navarre.
  • Willingness to participate on a voluntary basis.
  • Ability to ambulate with or without assistance.
  • Ability to communicate and collaborate with the research staff.

Exclusion criteria

Exclusion Criteria:

  • Acute illness that does not allow the assessment and practice of physical exercise during the study.
  • Medical for the practice of physical exercise.
  • Severe dementia.
  • Refusal to sign the form by the patient, accompanying person, or legal guardian.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Multicomponent intervention

    Physical exercise and cognitive exercises

    Behavioral: Physical exercise and cognitive exercises

  • No intervention
    Usual care

Interventions

  • BehavioralPhysical exercise and cognitive exercises

    The intervention will be based on the Vivifrail program, which is a multicomponent physical exercise program designed specifically for older adults.

06

What researchers measure

Primary outcomes

  1. Physical function

    Short Physical Performance Battery (SPPB): scores range from 0 to 12, with higher scores indicating better physicalfunction.

    Time frame: Within the first 24-48 hours of acute care admission (in hospital or home hospitalization), pre-intervention baseline, and immediately after the intervention.

  2. Cognitive function

    Mini-Mental State Examination (MMSE): scores range from 0 to 30, with higher scores indicating better cognitive function.

    Time frame: Within the first 24-48 hours of acute care admission (in hospital or home hospitalization), pre-intervention baseline, and immediately after the intervention.

  3. Physical activity

    Physical activity will be assessed with a Firstbeat device (format: hh:mm:ss).

    Time frame: During hospital stay or during home-base hospitalization .

  4. Sedentarism

    Sedentarism will be assessed with a Firstbeat device (format: hh:mm:ss).

    Time frame: During hospital stay or during home-based hospitalization.

Secondary outcomes

  1. Health-related quality of life (HRQOL)

    EQ-5D-5L provides a health profile that is converted to a utility index, in which 0 is equivalent to death and 1 indicates perfect health. Additionally, the EQ-VAS ranges from 0 to 100, with higher scores indicating better health.

    Time frame: Pre-intervention baseline and immediately after the intervention.

  2. Heart rate variability

    Heart rate variability will be assessed usign a Firstbeat device.

    Time frame: During hospital stay or during home-based hospitalization.

  3. Handgrip strength

    Handgrip strength will be measured using a handgrip dynamometer.

    Time frame: Within the first 24-48 hours of acute care admission (in hospital or home hospitalization), pre-intervention baseline, and immediately after the intervention.

  4. Sleep quantity

    Sleep duration will be recorded (format: hh:mm:ss).

    Time frame: During hospital stay or during home-based hospitalization.

  5. Sleep quality

    The heart rate variability parameter RMSSD (measured in ms) will be assessed during sleep.

    Time frame: During hospital stay or during home-based hospitalization.

  6. Energy expenditure

    Energy expenditure (kcal) will be assessed in with a Firstbeat device.

    Time frame: Within the first 24-48 hours of acute care admission (in hospital or home hospitalization), pre-intervention baseline, and immediately after the intervention.

  7. Rate of hospital readmissions

    Number of readmissions of each patient will be registered using the information from the medical records.

    Time frame: 3 months, 6 months, and 12 months post-discharge.

  8. Rate of falls

    The number of falls for each patient will be recorded through follow-up phone calls.

    Time frame: 3 months, 6 months, and 12 months post-discharge.

  9. Incidence of mortality

    Number of deaths will be registered using the information from the medical records.

    Time frame: 3 months, 6 months, and 12 months post-discharge.

  10. Rate of emergency visits

    Number of emergency visits will be registered using the information from the medical records.

    Time frame: 3 moths, 6 months, and 12 months post-discharge.

  11. Prescribed pharmacologic treatment

    All medications prescribed to each patient will be recorded using the information from the medical records.

    Time frame: Within the first 24-48 hours of acute care admission (in hospital or home hospitalization), pre-intervention baseline, and immediately after the intervention.

  12. Cost-effectiveness

    Cost-effectiveness will be assessed by calculating the cost per Quality-Adjusted Life Year (QALY) gained.

    Time frame: At pre-intervention baseline, at 3 months post-discharge, at 6 months post-discharge, and at 12 months post-discharge.

07

Study locations

1 of 1 sites recruiting
  • Navarrabiomed, Hospital Universitario de Navarra (HUN) - Universidad Pública de Navarra (UPNA), Pamplona, Spain
    Pamplona, Navarre 31015, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 2 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Start moved once since we started tracking on Sep 25, 2026: Oct 2025 → Oct 2026, on Oct 23, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2025
First posted
Sep 19, 2025
StartActual
Oct 22, 2026was Oct 2025
Primary completionEst.
Dec 2026
CompletionEst.
Jun 2027
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 23, 2026
Sites
1 site added — first site in Spain
Show site
  • Navarrabiomed, Hospital Universitario de Navarra (HUN) - Universidad Pública de Navarra (UPNA), Pamplona, Spain · Pamplona, Spain
Oct 23, 2026
Start date
Oct 2025→Oct 22, 2026 (actual)
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Spain
    Show site
    • Navarrabiomed, Hospital Universitario de Navarra (HUN) - Universidad Pública de Navarra (UPNA), Pamplona, Spain · Pamplona, Spain
    Start date Oct 2025→Oct 22, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07183241
Lead sponsor
Universidad Pública de Navarra
Responsible party
Sponsor
First posted
Sep 19, 2025
Start date
Oct 22, 2026
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Oct 23, 2026

Study contacts

Mikel Izquierdo, Professor
Contact
mikel.izquierdo@gmail.com
+34 948417876

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion